Adipokines of Epicardial Adipose Tissue and Atherosclerosis of Coronary Arteries
The Role of Adipokines Secreted by Epicardial Adipose Tissue in the Atherosclerosis of Coronary Arteries
1 other identifier
observational
160
1 country
1
Brief Summary
The aim of the study is to investigate whether the expression and production of adipokines secreted by the epicardial adipose tissue correlate with the degree of coronary atherosclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Oct 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 23, 2017
CompletedStudy Start
First participant enrolled
October 23, 2017
CompletedFirst Posted
Study publicly available on registry
October 26, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 22, 2018
CompletedOctober 26, 2017
October 1, 2017
3 months
October 23, 2017
October 23, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Association between coronary artery disease and epicardial adipokines
Comparison of the mRNA and protein production of four adipokines \[adiponectin, omentin-1, resistin, retinol binding protein-4(RBP4)\] from the epicardial adipose tissue between the territories that are supplied by LAD and RCA. This comparison will be performed in the following clusters of groups: 1. Cluster 1: NonDM-0 and DM-0 (comparison between territories that are supplied by non-stenosed coronary arteries) 2. Cluster 2: NonDM-LR and DM-LR (comparison between territories that are supplied by stenosed coronary arteries) 3. Cluster 3: NonDM-L, NonDM-R, DM-L and DM-R (comparison between a territory that is supplied by stenosed coronary artery and another territory that is supplied by non-stenosed coronary artery)
Baseline measurement
Secondary Outcomes (1)
Impact of diabetes on epicardial adipokines
Baseline measurement
Study Arms (8)
NonDM-0
Nondiabetics without significant stenoses (\> 50%) in the coronary arteries
NonDM-L
Nondiabetics with significant stenosis in the left anterior descending (LAD) coronary artery or in the Left main (LM) coronary artery, but without significant stenosis in the right coronary artery (RCA)
NonDM-R
Nondiabetics without significant stenosis in the LAD and in the LM, but with significant stenosis in the RCA
NonDM-LR
Nondiabetics with significant stenosis in the LAD or in the LM and with significant stenosis in the RCA
DM-0
Patients with type 2 diabetes mellitus (T2DM) without significant stenoses in the coronary arteries
DM-L
T2DM patients with significant stenosis in the LAD or in the LM, but without significant stenosis in RCA
DM-R
T2DM patients without significant stenosis in the LAD and in the LM, but with significant stenosis in the RCA
DM-LR
T2DM patients with significant stenosis in the LAD or in the LM and with significant stenosis in the RCA
Eligibility Criteria
Individuals undergoing cardiac surgery will be recruited in this study.
You may qualify if:
- \) Individuals undergoing cardiac surgery
You may not qualify if:
- Age \< 18 years
- HbA1c \> 7.0%
- Any change of antidiabetic medication the previous 3 months before the surgery
- GFR \< 60 mL/min/1.73 m2
- Liver disease
- Cancer
- Non-treated hyperthyroidism or hypothyroidism
- Autoimmune disease
- Infection
- Any change in body weight at least 5% the previous 3 months before surgery
- Significant dehydration.
- Taking any of the following drugs the previous 3 months before surgery: hormones, antiobesity drugs
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Ioannina
Ioannina, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Eustratios Apostolakis, Professor
University Hospital, Ioannina
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiologist, Postdoctoral researcher
Study Record Dates
First Submitted
October 23, 2017
First Posted
October 26, 2017
Study Start
October 23, 2017
Primary Completion
January 15, 2018
Study Completion
January 22, 2018
Last Updated
October 26, 2017
Record last verified: 2017-10